About

Transcatheter therapy of structural heart disease is advancing rapidly. Due to the less invasive approach, transcatheter techniques have replaced surgery as the standard procedure for atrial septal defect and patent foramen ovale closure.

Evolving interventional techniques allow treatment of paravalvular leaks, ventricular septal defects and valve replacement, especially the rapid evolution and newer indications for transcatheter aortic valve replacement (TAVR).

Related Articles

Articles

ISCHEMIA Trial: Key Questions and Answers

José López-Sendón, Raul Moreno, Juan Tamargo,

Published:

Citation: European Cardiology Review 2021;16:e34.

TAVI in Challenging Scenarios

Sandra Santos-Martínez, Ignacio J Amat-Santos,

Published:

Citation: European Cardiology Review 2021;16:e29.

APSC Consensus Recommendations for MitraClip in MR

Yeo Khung Keong, Jack Wei Chieh Tan, David WM Muller,

Published:

Citation: European Cardiology Review 2021;16:e25.

The ISCHEMIA Trial: What is the Message for the Interventionalist?

Emmanuel Ako, Sukhjinder Nijjer, Abtehale Al-Hussaini,

Published:

Citation: European Cardiology Review 2021;16:e24.